Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Paulina Seweryna Stanczak"'
Autor:
Pawel Dobrzanski, Bartłomiej Gielniewski, Paulina Seweryna Stanczak, Salwador Cyranowski, Marcin Grzybowski, Natalia Ochocka, Bozena Kaminska, Paulina Pilanc, Aleksandra Ellert-Miklaszewska, Roman Blaszczyk, Adria-Jaume Roura, Kamil Wojnicki
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
Glioblastomas (GBM) are the common and aggressive primary brain tumors that are incurable by conventional therapies. Immunotherapy with immune checkpoint inhibitors is not effective in GBM patients due to the highly immunosuppressive tumor microenvir
Autor:
Olga Sokolowska, Anna Sosnowska, Dominika Nowis, Tomasz P. Rygiel, Paweł Matryba, Paulina Seweryna Stanczak, Artur Wolny, Marcin Grzybowski, Justyna Chlebowska-Tuz, Tomasz M. Grzywa, Zofia Pilch, Zuzanna Rydzynska, Jakub Golab, Alan Greig, Roman Blaszczyk
Publikováno v:
Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
Immunotherapy has demonstrated significant activity in a broad range of cancer types, but still the majority of patients receiving it do not maintain durable therapeutic responses. Amino acid metabolism has been proposed to be involved in the regulat
Autor:
P. Pilanc-kudlek, Roman Blaszczyk, Kamil Wojnicki, Salwador Cyranowski, Paulina Seweryna Stanczak, P. Dobrzański, Natalia Ochocka, P. Pomper, Marcin Grzybowski, Bozena Kaminska, A. Gołębiowski
Publikováno v:
Annals of Oncology. 30:xi56-xi57
Background Glioblastoma (GBM) is a common and aggressive brain tumour, which is resistant to standard therapies. Clinical and experimental data demonstrated upregulation of Arginase 1 (ARG1) gene and protein in malignant gliomas, particularly in tumo
Autor:
J. Nowicka, A. Gołębiowski, J. Brzezińska, J. Olczak, B. Borek, Paulina Seweryna Stanczak, Marcin Grzybowski, J. Pęczkowicz-Szyszka, M. Dzięgielewski, A.M. Siwińska, A. Gzik, P. Wolska, J. Chrzanowski, E. Nikolaev, M. Welzer, P. Dobrzański, K. Dzwonek, K. Jędrzejczak, Roman Blaszczyk
Publikováno v:
Annals of Oncology. 30:v793-v794
Background Immunotherapies are considered the most promising therapeutic approach for cancer and the immunosuppressive activity of ARG1 has been recognized as an important mechanism of the tumor immune evasion. This prompted the development of argina
Autor:
Natalia Piórkowska, Delfina Popiel, Aleksandra Stanczak, Daria Zdżalik-Bielecka, Patrycja Olejkowska, Jerzy Pieczykolan, Maciej Wieczorek, Paulina Seweryna Stanczak, Marta Magdycz, Monika Lamparska-Przybysz, Joanna Hucz-Kalitowska, Joanna Lipner, Karolina Dzwonek, Abdellah Yamani, Krzysztof Dubiel
Publikováno v:
European Journal of Medicinal Chemistry. 210:112990
The FGFR family is characterized by four receptors (FGFR 1–4), binding to 18 ligands called fibroblast growth factors (FGFs). Aberrant activation of FGFs and their FGFRs has been implicated in a broad spectrum of human tumors. We employed the scaff
Autor:
Marek Dziegielewski, Karol Jedrzejczak, Bozena Kaminska, Adam Golebiowski, Paulina Seweryna Stanczak, Marcin Mikolaj Grzybowski, Anna Gzik, Bartlomiej Borek, Roman Blaszczyk, Paulina Wolska, Marcin Mazurkiewicz, Anna Maria Zdziarska, Anna Gieryng, Paulina Pilanc, Karolina Dzwonek, Pawel Dobrzanski
Publikováno v:
Molecular Cancer Therapeutics. 17:B003-B003
Depletion of arginine represents an important mechanism of immunosuppression, and high plasma and tumor arginase (ARG) activity has been demonstrated in patients with a wide spectrum of cancers and correlated with a poor prognosis. Low arginine level
Autor:
A. Gołębiowski, Marcin Grzybowski, Paulina Seweryna Stanczak, Kavita Ramji, Anna Sosnowska, J. Nowicka, Dominika Nowis, P. Dobrzański, Michał Mazurkiewicz, A.M. Zdziarska, P. Wolska, K. Dzwonek, Jakub Golab, Roman Blaszczyk
Publikováno v:
ResearcherID
Autor:
Marcin Mikołaj Grzybowski, Paulina Seweryna Stańczak, Paulina Pomper, Roman Błaszczyk, Bartłomiej Borek, Anna Gzik, Julita Nowicka, Karol Jędrzejczak, Joanna Brzezińska, Tomasz Rejczak, Nazan Cemre Güner-Chalimoniuk, Agnieszka Kikulska, Michał Mlącki, Jolanta Pęczkowicz-Szyszka, Jacek Olczak, Adam Gołębiowski, Karolina Dzwonek, Paweł Dobrzański, Zbigniew Zasłona
Publikováno v:
Cancers, Vol 14, Iss 16, p 3967 (2022)
Background: Arginases play essential roles in metabolic pathways, determining the fitness of both immune and tumour cells. Along with the previously validated role of ARG1 in cancer, the particular significance of ARG2 as a therapeutic target has eme
Externí odkaz:
https://doaj.org/article/d53563804a4d42dfa2111e074cebdbe0